Creators of a new machine-learning drug discovery platform Insilico Medicine has inked a dual-program drug discovery deal with Jiangsu Chia Tai Fenghai Pharmaceutical (CTFH) worth up to $200 million. Insilico CEO Alex Zhavoronkov. Why it matters...
Aging doubles your risks of chronic diseases every 8 years and there are genes responsible for that The global population aged 60 or over is growing faster than all younger age groups and faces the tide of chronic diseases threatening their quality of...
Moscow hosted the world’s first ever international Cybathlon today, as children and adults flocked to the city to compete to move everyday objects around using prosthetic hands, British newspaper The Sun reported on August 13. At the event, prosthesis...